Clinical Trial Update: Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating metabolic imaging to assess the aggressiveness of ovarian cancer. The study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 1 | Status: SUSPENDED